Obtaining approval to sell medical devices in Vietnam just got harder – and more costly – for importers. Starting in January, all medical devices marketed in the country will require approval by Vietnamese authorities. Previously, some devices already approved by the European... Read More
This article was originally featured on Medtech Intelligence. As Asia’s prostate cancer burden grows, so do opportunities for Western medical device companies with products to diagnose and treat the disease. Leading Western medical device firms are moving into markets across the Asian... Read More
With rates of hepatitis B infection higher in Asia than anywhere else on the globe, deaths from liver cancer are an overwhelmingly Asian phenomenon. Almost 80 percent of cases and deaths from liver cancer occur on the Asian continent, according to the... Read More
Spending on healthcare is expected to balloon by more than 70% over the next two decades in Malaysia, Indonesia, the Philippines, Singapore, Thailand and Vietnam, according to a report presented at the World Economic Forum. Total healthcare spending in the six nations... Read More
INTRODUCTION With incomes rising among its rapidly aging population of 96.7 million, Vietnam is a booming market for pharmaceuticals. Long one of the least-developed pharmaceutical markets in Asia, with relatively low per capita spending on drugs, Vietnam has tremendous potential. According to... Read More
As previously reported in February, Vietnam’s registration deadline for Class B, C, and D medical devices had been extended to January 1, 2019. Six months later, that deadline has been pushed back another year, until January 1, 2020. According to Nguyen Tuan... Read More
This article was originally published on Medtech Intelligence. This article is a continuation of the two-part series on the hospital sector in Asia. Last month’s article focused on China’s hospital growth. This month’s article will expand on the status and prospects of... Read More
The Association of Southeast Asian Nations (ASEAN), which is comprised of the countries Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Brunei, Laos, Myanmar, and Cambodia, was established in 1967 to promote peace and stability in the region, facilitate collaboration and mutual assistance among the... Read More
Vietnam’s pharmaceutical market is expected to surge from $4.7 billion in 2017 to $7.7 billion in 2021—a highrate of growth that is beginning to lure investors. This Spring Vingroup, Vietnam’s leading commercial real estate company, set its sights on the pharmaceutical sector,... Read More
This article was originally published on MedTech Intelligence. Driven largely by hepatitis in its various forms, liver disease has long been a fixture of life in China and Southeast Asia. Over the past three decades, public health programs in the region have... Read More